- Home
- ZVRA vs SCHL Comparison
ZVRA vs SCHL Comparison
Compare ZVRA & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVRA
- SCHL
- Stock Information
- Founded
- ZVRA 2006
- SCHL 1920
- Country
- ZVRA United States
- SCHL United States
- Employees
- ZVRA N/A
- SCHL N/A
- Industry
- ZVRA Biotechnology: Pharmaceutical Preparations
- SCHL Books
- Sector
- ZVRA Health Care
- SCHL Consumer Discretionary
- Exchange
- ZVRA Nasdaq
- SCHL Nasdaq
- Market Cap
- ZVRA 433.5M
- SCHL 501.9M
- IPO Year
- ZVRA 2015
- SCHL 1987
- Fundamental
- Price
- ZVRA $7.81
- SCHL $18.57
- Analyst Decision
- ZVRA Strong Buy
- SCHL
- Analyst Count
- ZVRA 8
- SCHL 0
- Target Price
- ZVRA $22.29
- SCHL N/A
- AVG Volume (30 Days)
- ZVRA 521.7K
- SCHL 558.9K
- Earning Date
- ZVRA 03-11-2025
- SCHL 03-20-2025
- Dividend Yield
- ZVRA N/A
- SCHL 4.25%
- EPS Growth
- ZVRA N/A
- SCHL N/A
- EPS
- ZVRA N/A
- SCHL 0.65
- Revenue
- ZVRA $23,612,000.00
- SCHL $1,592,100,000.00
- Revenue This Year
- ZVRA $281.10
- SCHL $5.93
- Revenue Next Year
- ZVRA $97.98
- SCHL $5.29
- P/E Ratio
- ZVRA N/A
- SCHL $28.84
- Revenue Growth
- ZVRA N/A
- SCHL N/A
- 52 Week Low
- ZVRA $4.20
- SCHL $17.72
- 52 Week High
- ZVRA $9.76
- SCHL $38.77
- Technical
- Relative Strength Index (RSI)
- ZVRA 49.43
- SCHL 40.65
- Support Level
- ZVRA $7.78
- SCHL $18.38
- Resistance Level
- ZVRA $8.33
- SCHL $21.85
- Average True Range (ATR)
- ZVRA 0.39
- SCHL 1.10
- MACD
- ZVRA -0.01
- SCHL -0.17
- Stochastic Oscillator
- ZVRA 52.99
- SCHL 3.87
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
About SCHL Scholastic Corporation
Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.